title: Treatment of late-life major depressive disorder with selective serotonin reuptake inhibitors improves the multidimensional prognostic index.
authors.forename: Alberto
authors.initials: A
authors.lastname: Pilotto
authors.forename: Grazia
authors.initials: G
authors.lastname: D'Onofrio
authors.forename: Francesco
authors.initials: F
authors.lastname: Panza
authors.forename: Massimiliano
authors.initials: M
authors.lastname: Copetti
authors.forename: Leandro
authors.initials: L
authors.lastname: Cascavilla
authors.forename: Francesco
authors.initials: F
authors.lastname: Paris
authors.forename: Fabio
authors.initials: F
authors.lastname: Pellegrini
authors.forename: Davide
authors.initials: D
authors.lastname: Seripa
authors.forename: Luigi
authors.initials: L
authors.lastname: Ferrucci
mesh_terms: D017668:Age of Onset; D000368:Aged; D000369:Aged, 80 and over; D003865:Major Depressive Disorder / Q000188:drug therapy* / Q000503:physiopathology; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D011379:Prognosis; D017367:Selective Serotonin Reuptake Inhibitors / Q000627:therapeutic use*; D013997:Time Factors; D016896:Treatment Outcome
chemical_list: D017367:Selective Serotonin Reuptake Inhibitors